GSK press releases Follow GSK enters agreement to acquire 35Pharma Inc. Includes HS235, a potentially best-in-class activin signaling inhibitor in clinical development for treatment of cardiopulmonary diseases https://www.gsk.com/en-gb/media/press-releases/gsk-enters-agreement-to-acquire-35pharma-inc/ gsk.com
